{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:17:21Z","timestamp":1767892641990,"version":"3.49.0"},"reference-count":33,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2022,6,9]]},"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Objective<\/jats:title>\n               <jats:p>To analyse the performance of the rheumatoid arthritis impact of disease (RAID) score in patients with ankylosing spondylitis, polymyalgia rheumatica, systemic lupus erythematosus, primary Sj\u00f6gren\u2019s syndrome, idiopathic inflammatory myositis and systemic sclerosis, as compared with rheumatoid arthritis (RA).<\/jats:p>\n               <jats:p>\n                  <jats:bold>Methods<\/jats:bold>\n               <\/jats:p>\n               <jats:p>A total of 12\u2009398 patients from the German National Database were included. For each diagnosis, we calculated age-adjusted\/sex-adjusted partial correlation coefficients between RAID and patient global (PtGl) health, PtGl disease activity, physician global (PhGl) disease activity, Well-Being Index (WHO-5) and EuroQoL-5 Dimensions (EQ-5D). As a measure of agreement, the mean differences between the RAID and other outcomes were compared with the respective differences for RA. The effect of each diagnosis on the difference between RAID and the other scores was assessed with linear regression, with RA as the reference.<\/jats:p>\n               <jats:p>\n                  <jats:bold>Results<\/jats:bold>\n               <\/jats:p>\n               <jats:p>Across all diagnoses, RAID correlated strongly with PtGl health (0.71\u20130.83), moderately to strongly with PtGl disease activity (0.59\u20130.79), WHO-5 (0.65\u20130.81) and EQ-5D (0.68\u20130.73) and weakly with PhGl disease activity (0.23\u20130.38). Mean differences were calculated for RAID and PtGl disease activity (0 to \u22120.6), PtGl health (\u22120.4 to \u22120.9), WHO-5 (\u22120.7 to \u22121.3), EQ-5D (1.1 to 1.7) and PhGl disease activity (1.4 to 2.2). Discrepancies between other scores and RAID were comparable to RA. Linear regression revealed no clinically relevant effect of any of the diagnoses on the difference between RAID and the other outcomes.<\/jats:p>\n               <jats:p>\n                  <jats:bold>Conclusion<\/jats:bold>\n               <\/jats:p>\n               <jats:p>The RAID score performs comparably across all diagnoses investigated. This supports the use of RAID for measuring the impact also of other rheumatic diseases.<\/jats:p>","DOI":"10.1136\/rmdopen-2022-002342","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T12:12:33Z","timestamp":1657109553000},"page":"e002342","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1655-0595","authenticated-orcid":false,"given":"Katja","family":"Thiele","sequence":"first","affiliation":[{"name":"Epidemiology and Health Services Research, German Rheumatism Research Center Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-0294","authenticated-orcid":false,"given":"Katinka","family":"Albrecht","sequence":"additional","affiliation":[{"name":"Epidemiology and Health Services Research, German Rheumatism Research Center Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Zink","sequence":"additional","affiliation":[{"name":"Epidemiology and Health Services Research, German Rheumatism Research Center Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Aringer","sequence":"additional","affiliation":[{"name":"Devision of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Karberg","sequence":"additional","affiliation":[{"name":"Rheumatology and Internal Medicine, Practice Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Sp\u00e4thling-Mestekemper","sequence":"additional","affiliation":[{"name":"Rheumatology, Practice Munich, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"von Hin\u00fcber","sequence":"additional","affiliation":[{"name":"Rheumatology, Practice Hildesheim, Hildesheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-2728","authenticated-orcid":false,"given":"Johanna","family":"Callhoff","sequence":"additional","affiliation":[{"name":"Epidemiology and Health Services Research, German Rheumatism Research Center Berlin, Berlin, Germany"},{"name":"Institute for Social Medicine, Epidemiology and Health Economics, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"2025090313155380000_8.2.e002342.1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142901"},{"key":"2025090313155380000_8.2.e002342.2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jbspin.2017.05.020","article-title":"Validity of the rheumatoid arthritis impact of disease (raid) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis","volume":"85","author":"Salaffi","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2025090313155380000_8.2.e002342.3","doi-asserted-by":"crossref","first-page":"rkaa013","DOI":"10.1093\/rap\/rkaa013","article-title":"Use of rheumatoid arthritis impact of disease (raid) in routine care; identification of DAS28 remission and unmet patient-reported outcomes","volume":"4","author":"Mistry","year":"2020","journal-title":"Rheumatol Adv Pract"},{"key":"2025090313155380000_8.2.e002342.4","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/rheumatology\/kex211","article-title":"Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients","volume":"56","author":"Ferreira","year":"2017","journal-title":"Rheumatology"},{"key":"2025090313155380000_8.2.e002342.5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/acr.23284","article-title":"Suppressing inflammation in rheumatoid arthritis: does patient global assessment blur the target? A practice-based call for a paradigm change","volume":"70","author":"Ferreira","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2025090313155380000_8.2.e002342.6","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/annrheumdis-2017-212934","article-title":"Determinants of happiness and quality of life in patients with rheumatoid arthritis: a structural equation modelling approach","volume":"77","author":"Santos","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2025090313155380000_8.2.e002342.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.145375"},{"key":"2025090313155380000_8.2.e002342.8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100700"},{"key":"2025090313155380000_8.2.e002342.9","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001539"},{"key":"2025090313155380000_8.2.e002342.10","first-page":"e2021238","article-title":"Rheumatoid arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures","volume":"92","author":"Salaffi","year":"2021","journal-title":"Acta Biomed"},{"key":"2025090313155380000_8.2.e002342.11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205207"},{"key":"2025090313155380000_8.2.e002342.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-019-0680-1"},{"key":"2025090313155380000_8.2.e002342.13","first-page":"S14","article-title":"Measures of rheumatoid arthritis disease activity: patient (PtGA) and provider (PrGA) global assessment of disease activity, disease activity score (DAS) and disease activity score with 28-Joint counts (DAS28), simplified disease activity index (SDAI), clinical disease activity index (CDAI), patient activity score (PAS) and patient activity Score-II (PASII), routine assessment of patient index data (rapid), rheumatoid arthritis disease activity index (radai) and rheumatoid arthritis disease activity Index-5 (RADAI-5), chronic arthritis systemic index (CASI), patient-based disease activity score with ESR (PDAS1) and patient-based disease activity score without ESR (PDAS2), and mean overall index for rheumatoid arthritis (MOI-RA)","volume":"63 Suppl 11","author":"Anderson","year":"2011","journal-title":"Arthritis Care Res"},{"key":"2025090313155380000_8.2.e002342.14","first-page":"II27","article-title":"Validity of the five-item who well-being index (WHO-5) in an elderly population","volume":"251 Suppl 2","author":"Bonsignore","year":"2001","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2025090313155380000_8.2.e002342.15","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-003-0182-5"},{"key":"2025090313155380000_8.2.e002342.16","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"2025090313155380000_8.2.e002342.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2006.03.012"},{"key":"2025090313155380000_8.2.e002342.18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.143032"},{"key":"2025090313155380000_8.2.e002342.19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40744-019-00172-9","article-title":"Comparative disease burden in patients with rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis: data from two Corrona registries","volume":"6","author":"Mease","year":"2019","journal-title":"Rheumatol Ther"},{"key":"2025090313155380000_8.2.e002342.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123582"},{"key":"2025090313155380000_8.2.e002342.21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s10067-016-3522-4","article-title":"Patient-reported outcomes in Asia: evaluation of the properties of the rheumatoid arthritis impact of disease (raid) score in multiethnic Asian patients with rheumatoid arthritis","volume":"36","author":"Cheung","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2025090313155380000_8.2.e002342.22","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181065"},{"key":"2025090313155380000_8.2.e002342.23","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22349"},{"key":"2025090313155380000_8.2.e002342.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)90884-8"},{"key":"2025090313155380000_8.2.e002342.25","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-20"},{"key":"2025090313155380000_8.2.e002342.26","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.104018"},{"key":"2025090313155380000_8.2.e002342.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204615"},{"key":"2025090313155380000_8.2.e002342.28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200248"},{"key":"2025090313155380000_8.2.e002342.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-014-0116-1","article-title":"Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance","volume":"12","author":"Holloway","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"2025090313155380000_8.2.e002342.30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrrheum.2015.116","article-title":"Patient-reported outcomes in core domain sets for rheumatic diseases","volume":"11","author":"van tuyl","year":"2015","journal-title":"nat rev rheumatol"},{"key":"2025090313155380000_8.2.e002342.31","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00296-020-04634-0","article-title":"Trends in idiopathic inflammatory myopathies: cross-sectional data from the German national database","volume":"40","author":"Albrecht","year":"2020","journal-title":"Rheumatol Int"},{"key":"2025090313155380000_8.2.e002342.32","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090372"},{"key":"2025090313155380000_8.2.e002342.33","doi-asserted-by":"crossref","unstructured":"ter Wee MM , van Tuyl LH , Blomjous BS , et al . Content validity of the Dutch rheumatoid arthritis impact of disease (raid) score: results of focus group discussions in established rheumatoid arthritis patients and comparison with the International classification of functioning, disability and health core set for rheumatoid arthritis. Arthritis Res Ther 2016;18.doi:10.1186\/s13075-015-0911-z","DOI":"10.1186\/s13075-015-0911-z"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2022-002342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:16:04Z","timestamp":1756930564000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2022-002342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,7,6]]},"published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1136\/rmdopen-2022-002342"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2022-002342","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}